A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis ...

A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave University of Michigan researchers a first ...

The gut microbiome comprises the trillions of bacteria and other microorganisms that live in our digestive tracts, and it has ...

Multiple Sclerosis Market Growth is Driven by Advanced Treatment Solutions and Rising Patient PopulationsPune, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Multiple Sclerosis Market Size & Growth Analysis: ...

A new study has found that the gut microbiome plays a crucial role in the development of multiple sclerosis (MS), an autoimmune disease that affects the central nervous system. The findings may ...

Dr Annalisa Morgan previews discussions on disease-modifying therapies, emerging treatments such as CAR T-cell therapy, and ...

Susie Wyss used to inject herself daily with a medication for multiple sclerosis ... therapies are now approved to treat MS. The treatments range from oral medications to infusions to help ...

While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Susie Wyss used to inject herself daily with a medication for multiple sclerosis ... therapies are now approved to treat MS. The treatments range from oral medications to infusions to help ...

Gut microbiome plays a significant role in the onset of multiple sclerosis (MS) -- an autoimmune disease that impacts the ce ...